tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

DMAC Stock Latest News

Promising Potential of Diamedica Therapeutics’ DM199 in Preeclampsia Treatment Drives Buy Rating
RatingsPromising Potential of Diamedica Therapeutics’ DM199 in Preeclampsia Treatment Drives Buy Rating
9d ago
DMAC
DiaMedica Therapeutics’ Earnings Call Highlights Progress and Stability
PremiumCompany Announcements
DiaMedica Therapeutics’ Earnings Call Highlights Progress and Stability
23d ago
DMAC
DiaMedica Elects Directors at Annual Meeting
PremiumCompany Announcements
DiaMedica Elects Directors at Annual Meeting
23d ago
8K
DMAC
DiaMedica Therapeutics Reports Q1 2025 Financials and Trial Progress
PremiumCompany Announcements
DiaMedica Therapeutics Reports Q1 2025 Financials and Trial Progress
24d ago
DMAC
DiaMedica Therapeutics Reports Q1 2025 Financial Results and Clinical Progress
PremiumCompany Announcements
DiaMedica Therapeutics Reports Q1 2025 Financial Results and Clinical Progress
25d ago
DMAC
DiaMedica Therapeutics reports Q1 EPS (18c), consensus (18c)
PremiumThe FlyDiaMedica Therapeutics reports Q1 EPS (18c), consensus (18c)
25d ago
DMAC
DMAC Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
DMAC Upcoming Earnings Report: What to Expect?
27d ago
DMAC
Buy Rating for Diamedica Therapeutics Driven by Promising DM199 Developments and Upcoming Trial Results
Premium
Ratings
Buy Rating for Diamedica Therapeutics Driven by Promising DM199 Developments and Upcoming Trial Results
3M ago
DMAC
DiaMedica Therapeutics price target raised to $10 from $7 at H.C. Wainwright
PremiumThe Fly
DiaMedica Therapeutics price target raised to $10 from $7 at H.C. Wainwright
3M ago
DMAC
DiaMedica Therapeutics Reports 2024 Financial Results
PremiumCompany Announcements
DiaMedica Therapeutics Reports 2024 Financial Results
3M ago
DMAC
DiaMedica Therapeutics’ Optimistic Earnings Call Highlights
PremiumCompany Announcements
DiaMedica Therapeutics’ Optimistic Earnings Call Highlights
3M ago
DMAC
DiaMedica Therapeutics Reports 2024 Financial Results and Strategic Advancements
PremiumCompany Announcements
DiaMedica Therapeutics Reports 2024 Financial Results and Strategic Advancements
3M ago
DMAC
DiaMedica Therapeutics reports FY24 EPS (60c), consensus (59c)
PremiumThe FlyDiaMedica Therapeutics reports FY24 EPS (60c), consensus (59c)
3M ago
DMAC
DMAC Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
DMAC Earnings this Week: How Will it Perform?
3M ago
DMAC
DiaMedica Therapeutics Appoints Daniel J. O’Connor to Board
Premium
Company Announcements
DiaMedica Therapeutics Appoints Daniel J. O’Connor to Board
3M ago
8K
DMAC
DiaMedica Therapeutics publishes DM199 data in Stroke
PremiumThe Fly
DiaMedica Therapeutics publishes DM199 data in Stroke
4M ago
DMAC
DiaMedica Therapeutics price target raised to $11 from $7 at Lake Street
PremiumThe Fly
DiaMedica Therapeutics price target raised to $11 from $7 at Lake Street
5M ago
DMAC
DiaMedica Therapeutics management to meet virtually with Lake Street
PremiumThe Fly
DiaMedica Therapeutics management to meet virtually with Lake Street
6M ago
DMAC
DiaMedica Therapeutics Reports Q3 2024 Financial Results
PremiumCompany Announcements
DiaMedica Therapeutics Reports Q3 2024 Financial Results
7M ago
DMAC
DiaMedica Therapeutics Advances Trials and Financial Position
PremiumCompany AnnouncementsDiaMedica Therapeutics Advances Trials and Financial Position
7M ago
8K
DMAC
DiaMedica Therapeutics reports Q3 EPS (15c), consensus (15c)
Premium
The Fly
DiaMedica Therapeutics reports Q3 EPS (15c), consensus (15c)
7M ago
DMAC
DiaMedica Therapeutics doses first patient in Phase 2 DM199 trial
Premium
The Fly
DiaMedica Therapeutics doses first patient in Phase 2 DM199 trial
7M ago
DMAC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >